-
Stocks on the move: Diamond Foods (NASDAQ:DMND), Wells Fargo & Company (NYSE:WFC), Cordia Bancorp (NASDAQ:BVA), ImmunoGen (NASDAQ:IMGN), Seventy Seven Energy (NYSE:SSE)
Zacks reiterated their neutral rating on shares of Diamond Foods (NASDAQ:DMND) in a research report released on Tuesday morning. Zacks currently has a $28.00 price objective on the stock. On Friday shares of Diamond Foods, Inc. (NASDAQ:DMND) closed at $24.58. Company’s sales growth for last 5 years was 8.70% and EPS growth for next 5…
-
Keep Eyes on: Transocean (NYSE:RIG), ImmunoGen (NASDAQ:IMGN), Chevron Corporation (NYSE:CVX), Applied Genetic Technologies Corporation (NASDAQ:AGTC), Northern Trust Corporation (NASDAQ:NTRS)
Zacks reaffirmed their neutral rating on shares of Transocean LTD (NYSE:RIG) in a research note issued to investors on Wednesday. The firm currently has a $16.00 price target on the stock. On Friday shares of Transocean Ltd. (NYSE:RIG) closed at $16.30. Company’s sales growth for last 5 years was -5.60%. ImmunoGen, Inc. (NASDAQ:IMGN), reported net…
-
Biotech Volatile Stocks: ImmunoGen (NASDAQ:IMGN), Genetic Technologies Limited (NASDAQ:GENE), TrovaGene (NASDAQ:TROV), Repligen Corporation (NASDAQ:RGEN), Vitae Pharmaceuticals (NASDAQ:VTAE)
ImmunoGen, Inc. (NASDAQ:IMGN) reported fiscal second quarter earnings. The company announced net income of $13.6 million, or $0.16 per share, substantially -$0.21- above Capital IQ’s Consensus Estimate of a $0.05 per share loss, and also up from the same quarter last year, which saw net income of $3.8 million, or $0.04 per share. On Friday…
-
Biotech Bullish Stocks: ImmunoGen (NASDAQ:IMGN), Spark Therapeutics (NASDAQ:ONCE), Biogen Idec Inc. (NASDAQ:BIIB), Regado Biosciences (NASDAQ:RGDO), CorMedix (NYSEMKT:CRMD)
For the Company’s quarter ended December 31, 2014 (2Q, FY2015), ImmunoGen Inc. (NASDAQ:IMGN) reported net income of $13.6 million, or $0.16 per basic and diluted share, compared to net income of $3.8 million, or $0.04 per basic and diluted share, for the same quarter last year (2Q, FY2014). On Friday shares of ImmunoGen, Inc. (NASDAQ:IMGN)…
-
5 Stock in Different Moves: ImmunoGen (NASDAQ:IMGN), Immune Pharmaceuticals (NASDAQ:IMNP), Comcast Corporation (NASDAQ:CMCSA), Royal Caribbean Cruises (NYSE:RCL), Wal-Mart Stores (NYSE:WMT)
ImmunoGen, Inc. (NASDAQ:IMGN) reported financial results for the three-month period ended December 31, 2014 – the second quarter of the Company’s 2015 fiscal year (2QFY2015). For the Company’s quarter ended December 31, 2014 (2QFY2015), ImmunoGen reported net income of $13.6 million, or $0.16 per basic and diluted share, compared to net income of $3.8 million,…
-
Premarket Gainers to Watch: Books-A-Million Inc. (NASDAQ:BAMM), Intercept Pharmaceuticals (NASDAQ:ICPT), ImmunoGen (NASDAQ:IMGN), Performant Financial Corporation (NASDAQ:PFMT), Synaptics Inc. (NASDAQ:SYNA)
Books-A-Million Inc. (NASDAQ:BAMM) announced Thursday that it has received a non-binding proposal from Clyde Anderson, Executive Chairman of the Company, on behalf of the Anderson family, to acquire certain outstanding shares of the common stock of Books-A-Million, Inc., at a cash purchase price of $2.75 per share. On Thursday shares of Books-A-Million Inc. (NASDAQ:BAMM) closed…
-
Trending Tickers: Costco Wholesale Corporation (NASDAQ:COST), ImmunoGen (NASDAQ:IMGN), Eli Lilly and Company (NYSE:LLY), Delta Air Lines (NYSE:DAL), Mattel (NASDAQ:MAT)
Costco Wholesale Corporation (NASDAQ:COST) said that it will spend $2.2 billion to pay out a one-time dividend of $5 a share. Costco said the special dividend, which is in addition to its quarterly dividend of 36 cents a share, will be funded through existing cash and additional borrowings. On Thursday shares of Costco Wholesale Corporation…
-
Hot Runners: ImmunoGen (NASDAQ:IMGN), Ruthigen (NASDAQ:RTGN), Micrel Inc. (NASDAQ:MCRL), Whirlpool Corp. (NYSE:WHR), Westmoreland Coal Co. (NASDAQ:WLB)
ImmunoGen, Inc. (NASDAQ:IMGN), a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate (ADC) technology, announced that the Company will host a conference call at 8:00 a.m. ET on Friday, January 30, 2015, to discuss ImmunoGen’s financial results for the three-month period ended December 31, 2014, the second quarter of its 2015 fiscal…
-
Hot Runners: Wells Fargo & Company (NYSE:WFC), Groupon (NASDAQ:GRPN), Neurocrine Biosciences Inc. (NASDAQ:NBIX), ImmunoGen (NASDAQ:IMGN), Janus Capital Group (NYSE:JNS)
Wells Fargo & Company (NYSE: WFC) said that Chief Financial Officer John Shrewsberry will present at the 16th Annual Credit Suisse Financial Services Forum in Aventura, Florida, on Tuesday, February 10, at 11 a.m. Eastern Time (8 a.m. Pacific Time).On Friday shares of Wells Fargo & Company (NYSE:WFC) closed at $53.26. Company’s sales growth for…
-
5 Stocks in Dramatic Moves: ImmunoGen (NASDAQ:IMGN), U.S. Bancorp (NYSE:USB), NetEase (NASDAQ:NTES), Ventas (NYSE:VTR), Viad Corp (NYSE:VVI)
On January 13, 2015, Novartis Institutes for BioMedical Research, Inc. (“Novartis”) notified ImmunoGen, Inc. (NASDAQ:IMGN) that it had initiated Phase I, first-in-human clinical testing of a product candidate, LOP628, utilizing our antibody-drug conjugate (ADC) technology. Pursuant to the license taken under our 2010 Multi-Target Agreement, this start of clinical testing triggers a $5 million milestone…